A Clinical Trial to Investigate the Efficacy of the Brain Blossom Supplement to Improve Cognitive Function and Memory
NCT07564804 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2026-05-04
Summary
This study evaluates the efficacy of BioNatureHealth's Brain Blossom supplement in improving cognitive function and memory in adults aged 50-70 years. Participants will be randomized to receive either the test product or placebo over 8 weeks, with cognitive battery testing and questionnaires administered at multiple timepoints.
Conditions
- Cognitive Function
- Memory
- Cognitive Decline
Interventions
- DIETARY_SUPPLEMENT
-
Dietary Supplement: Brain Blossom
Six capsules taken once daily in the morning with water.
- DIETARY_SUPPLEMENT
-
Placebo
Rice flour capsules
Sponsors & Collaborators
-
Citruslabs
collaborator INDUSTRY -
Bio Nature Health
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 50 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-03-28
- Primary Completion
- 2025-06-27
- Completion
- 2025-06-27
Countries
- United States
Study Locations
More Related Trials
-
Crossover Trial for Nicotinamide Riboside in Subjective Cognitive Decline and Mild Cognitive Impairment
NCT04078178 ·Status: COMPLETED ·Phase: NA
-
NAD Therapy for Improving Memory and Brain Blood Flow in Older Adults With Mild Cognitive Impairment
NCT03482167 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Clinical Trial to Investigate the Safety and Efficacy of AP-Brain on Cognitive Function at Varying Dosages in Healthy Middle-aged and Older Adults With Self-reported Memory Problems
NCT07388043 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Efficacy of MEMORMAX in Subjects With MCI
NCT03581929 ·Status: COMPLETED ·Phase: NA
-
A Clinical Trial of a Vitamin/Nutriceutical Formulation for Alzheimer's Disease
NCT01320527 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study of Nicotinamide to Treat Alzheimer's Disease
NCT00580931 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of the Effects of Cerefolin NAC on Inflammation Blood Markers in Older Individuals With Memory Complaints
NCT00597376 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Effects of a Nutritional Intervention of Ketogenic Medium-chain Triglycerides and B-vitamins on Cognitive Functioning in Older Adults With Mild Cognitive Impairment (COGNIKET-MCI)
NCT06347315 ·Status: RECRUITING ·Phase: NA
-
Safety and Pharmacokinetics of Single Ascending Doses and Multiple Ascending Doses of CS6253 in Healthy Volunteers
NCT05965414 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Prospective, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of LasoperinTM on Cognitive Function in Healthy Adults
NCT05994391 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Genistein in Mild Cognitive Impairment
NCT07385937 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Curcumin in Patients With Mild to Moderate Alzheimer's Disease
NCT00099710 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of CT1812 in Healthy Adult Male Subjects
NCT05225389 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Investigating the Effectiveness of a LifeSeasons NeuroQ Supplement With Lifestyle Changes to Improve Cognitive Function in Healthy Adults Who Have One or More Risk Factors for Cognitive Decline
NCT04149639 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of AD-35 in Treatment of Subjects With Mild to Moderate Alzheimer's Disease
NCT03625401 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.
NCT03507790 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Safety and Efficacy of NeuroQ on Cognitive Function in Health Adults with Self-Reported Memory Problems
NCT06672094 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of PRJ212 to Improve the Memory of Patients With Mild Severity Alzheimer's Disease
NCT02991235 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of NVP-NK4146 in Patients with Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
NCT06761066 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Preventing Cognitive Decline With Alternative Therapies
NCT00010920 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of 1612 Capsules in aMnestic Mild Cognitive Impairment
NCT02982642 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831
NCT03538522 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease
NCT00359944 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Yangxue Qingnao Pills in the Treatment of Mild to Moderate Alzheimer's Disease
NCT04780399 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of AGB101 in Mild Cognitive Impairment Due to Alzheimer's Disease
NCT03486938 ·Status: COMPLETED ·Phase: PHASE2/PHASE3